» Articles » PMID: 9557714

Chemokine Receptor Utilization by Human Immunodeficiency Virus Type 1 Isolates That Replicate in Microglia

Overview
Journal J Virol
Date 1998 Apr 29
PMID 9557714
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The role of human immunodeficiency virus (HIV) strain variability remains a key unanswered question in HIV dementia, a condition affecting around 20% of infected individuals. Several groups have shown that viruses within the central nervous system (CNS) of infected patients constitute an independently evolving subset of HIV strains. A potential explanation for the replication and sequestration of viruses within the CNS is the preferential use of certain chemokine receptors present in microglia. To determine the role of specific chemokine coreceptors in infection of adult microglial cells, we obtained a small panel of HIV type 1 brain isolates, as well as other HIV strains that replicate well in cultured microglial cells. These viruses and molecular clones of their envelopes were used in infections, in cell-to-cell fusion assays, and in the construction of pseudotypes. The results demonstrate the predominant use of CCR5, at least among the major coreceptors, with minor use of CCR3 and CXCR4 by some of the isolates or their envelope clones.

Citing Articles

An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.

Gong Y, Zhi K, Nagesh P, Sinha N, Chowdhury P, Chen H Viruses. 2020; 12(5).

PMID: 32443728 PMC: 7290679. DOI: 10.3390/v12050564.


Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.

Evering T Curr HIV/AIDS Rep. 2018; 15(1):72-83.

PMID: 29460224 DOI: 10.1007/s11904-018-0374-3.


HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.

Carroll A, Brew B F1000Res. 2017; 6:312.

PMID: 28413625 PMC: 5365228. DOI: 10.12688/f1000research.10651.1.


Development and characterization of a human microglia cell model of HIV-1 infection.

Rawat P, Spector S J Neurovirol. 2016; 23(1):33-46.

PMID: 27538994 PMC: 5593752. DOI: 10.1007/s13365-016-0472-1.


Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?.

Shahbaz S, Manicardi M, Guaraldi G, Raggi P World J Cardiol. 2015; 7(10):633-44.

PMID: 26516417 PMC: 4620074. DOI: 10.4330/wjc.v7.i10.633.


References
1.
Epstein L, Kuiken C, Blumberg B, Hartman S, Sharer L, Clement M . HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology. 1991; 180(2):583-90. DOI: 10.1016/0042-6822(91)90072-j. View

2.
Gartner S, Popovic M . Macrophage tropism of HIV-1. AIDS Res Hum Retroviruses. 1990; 6(8):1017-21. DOI: 10.1089/aid.1990.6.1017. View

3.
Li Y, Kappes J, Conway J, Price R, Shaw G, Hahn B . Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol. 1991; 65(8):3973-85. PMC: 248827. DOI: 10.1128/JVI.65.8.3973-3985.1991. View

4.
Sharer L . Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol. 1992; 51(1):3-11. DOI: 10.1097/00005072-199201000-00002. View

5.
Davis L, Hjelle B, Miller V, PALMER D, Llewellyn A, Merlin T . Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992; 42(9):1736-9. DOI: 10.1212/wnl.42.9.1736. View